KOC
Koss-Olinger Consulting’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
78,946
-5,024
| -6% | -$122K | 0.16% | 78 |
|
|
2025
Q1 | $2.13M | Buy |
83,970
+3,569
| +4% | +$90.4K | 0.18% | 63 |
|
|
2024
Q4 | $2.13M | Buy |
80,401
+2,020
| +3% | +$53.6K | 0.19% | 62 |
|
|
2024
Q3 | $2.27M | Buy |
78,381
+1,599
| +2% | +$46.3K | 0.2% | 67 |
|
|
2024
Q2 | $2.15M | Buy |
+76,782
| New | +$2.15M | 0.2% | 66 |
|
|
2024
Q1 | – | Sell |
-47,205
| Closed | -$1.36M | – | 223 |
|
|
2023
Q4 | $1.36M | Buy |
47,205
+34,074
| +259% | +$981K | 0.13% | 86 |
|
|
2023
Q3 | $436K | Buy |
+13,131
| New | +$436K | 0.06% | 139 |
|
|
2022
Q3 | – | Sell |
-4,482
| Closed | -$235K | – | 233 |
|
|
2022
Q2 | $235K | Sell |
4,482
-1,712
| -28% | -$89.8K | 0.04% | 149 |
|
|
2022
Q1 | $321K | Sell |
6,194
-1,680
| -21% | -$87.1K | 0.05% | 143 |
|
|
2021
Q4 | $465K | Sell |
7,874
-1,911
| -20% | -$113K | 0.07% | 117 |
|
|
2021
Q3 | $421K | Sell |
9,785
-1,802
| -16% | -$77.5K | 0.07% | 131 |
|
|
2021
Q2 | $454K | Sell |
11,587
-991
| -8% | -$38.8K | 0.07% | 144 |
|
|
2021
Q1 | $456K | Buy |
+12,578
| New | +$456K | 0.08% | 136 |
|